2021 Vol.39, N°6 - Suppl.133 - Table of contents
Sjögren's syndrome 2021
Fourth Annual Supplement on Sjögren’s syndrome
Guest Editors: M. Bombardieri, H. Bootsma, S. De Vita, T. Dörner, M. Ramos-Casals, A.G. Tzioufas
One year in review
CER15298
2021,39,6,Suppl.133
Pg. 0003-0013
Free to view
One year in review 2021: Sjögren’s syndrome
G. Cafaro, R. Bursi, L.G. Chatzis, G. Fulvio, F. Ferro, E. Bartoloni, C. Baldini
DOI: https://doi.org/10.55563/clinexprheumatol/eojaol
G. Cafaro, R. Bursi, L.G. Chatzis, G. Fulvio, F. Ferro, E. Bartoloni, C. Baldini
DOI: https://doi.org/10.55563/clinexprheumatol/eojaol
Editorials
CER14877
2021,39,6,Suppl.133
Pg. 0014-0016
Free to view
Sjögren's: the European patients’ community perspective
A. Vieira, A. Grosjean, L. Stone, M. Oosterbaan, C. Bouillot, J. Koelewijn-Tukker, K. Antonopoulou
DOI: https://doi.org/10.55563/clinexprheumatol/8vip9k
A. Vieira, A. Grosjean, L. Stone, M. Oosterbaan, C. Bouillot, J. Koelewijn-Tukker, K. Antonopoulou
DOI: https://doi.org/10.55563/clinexprheumatol/8vip9k
CER14859
2021,39,6,Suppl.133
Pg. 0017-0019
Free to view
The clinical and technical impact of the HarmonicSS project
A.V. Goules, T.P. Exarchos, D.I. Fotiadis, A. Tzioufas
DOI: https://doi.org/10.55563/clinexprheumatol/u7knfy
A.V. Goules, T.P. Exarchos, D.I. Fotiadis, A. Tzioufas
DOI: https://doi.org/10.55563/clinexprheumatol/u7knfy
CER14844
2021,39,6,Suppl.133
Pg. 0020-0022
Free to view
Undernutrition and sarcopenic obesity: underrecognised conditions in patients with Sjögren’s syndrome?
H. Jager-Wittenaar, A. Vissink, F.G. Kroese, H. Bootsma
DOI: https://doi.org/10.55563/clinexprheumatol/9tnksi
H. Jager-Wittenaar, A. Vissink, F.G. Kroese, H. Bootsma
DOI: https://doi.org/10.55563/clinexprheumatol/9tnksi
Aetiopathogenesis
CER14387
2021,39,6,Suppl.133
Pg. 0023-0029
Free to view
Untargeted serum metabolomics and potential biomarkers for Sjögren’s syndrome
T. Xu, Y. Guo, J. Lu, J. Shan, L. Lin, W. Qian, W. Chen, J. Wang, X. Lv, M. Ke, D. Kong, Q. Shen, Y. Zhu, P. Liu, J. Su, W. Lu, Y. Li, P. Gao, S. Liu
DOI: https://doi.org/10.55563/clinexprheumatol/ylte6v
T. Xu, Y. Guo, J. Lu, J. Shan, L. Lin, W. Qian, W. Chen, J. Wang, X. Lv, M. Ke, D. Kong, Q. Shen, Y. Zhu, P. Liu, J. Su, W. Lu, Y. Li, P. Gao, S. Liu
DOI: https://doi.org/10.55563/clinexprheumatol/ylte6v
CER14927
2021,39,6,Suppl.133
Pg. 0030-0038
Free to view
Parotid salivary sodium levels of Sjögren’s syndrome patients suggest B-cell mediated epithelial sodium channel disruption
S.A. Pringle, B. Berkhof, M. Van Ginkel, S. Liefers, B. Van Der Vegt, F.K. Spijkervet, H. Bootsma, A. Vissink, F.G.M. Kroese
DOI: https://doi.org/10.55563/clinexprheumatol/h9hivf
S.A. Pringle, B. Berkhof, M. Van Ginkel, S. Liefers, B. Van Der Vegt, F.K. Spijkervet, H. Bootsma, A. Vissink, F.G.M. Kroese
DOI: https://doi.org/10.55563/clinexprheumatol/h9hivf
CER14883
2021,39,6,Suppl.133
Pg. 0039-0048
Free to view
Stepwise changes in the murine salivary gland immune response during virally-induced ectopic lymphoid structure formation
R. Coleby, D. Lucchesi, E. Pontarini, C. Pitzalis, M. Bombardieri
DOI: https://doi.org/10.55563/clinexprheumatol/gb7pfc
R. Coleby, D. Lucchesi, E. Pontarini, C. Pitzalis, M. Bombardieri
DOI: https://doi.org/10.55563/clinexprheumatol/gb7pfc
CER14962
2021,39,6,Suppl.133
Pg. 0049-0056
Free to view
Differential Th follicular cell subsets in minor salivary glands of patients with primary Sjögren's syndrome and systemic lupus erythematosus associated with Sjögren’s syndrome
G. Hernandez-Molina, V. Soto-Abraham, V. Zamora-Legoff, J. Furuzawa-Carballeda
DOI: https://doi.org/10.55563/clinexprheumatol/yuj21y
G. Hernandez-Molina, V. Soto-Abraham, V. Zamora-Legoff, J. Furuzawa-Carballeda
DOI: https://doi.org/10.55563/clinexprheumatol/yuj21y
Clinical aspects
CER14908
2021,39,6,Suppl.133
Pg. 0057-0065
Free to view
Post-COVID-19 syndrome in patients with primary Sjögren's syndrome after acute SARS-CoV-2 infection
P. Brito-Zerón, N. Acar-Denizli, V.C. Romão, B. Armagan, R. Seror, F. Carubbi, S. Melchor, R. Priori, V. Valim, S. Retamozo, S.G. Pasoto, V.F.M. Trevisani, B. Hofauer, A. Szántó, N. Inanc, G. Hernández-Molina, A. Sebastian, E. Bartoloni, V. Devauchelle-Pensec, M. Akasbi, F. Giardina, M. Bandeira, A. Sisó-Almirall, M. Ramos-Casals
on behalf of the Sjögren Big Data Consortium
DOI: https://doi.org/10.55563/clinexprheumatol/0anatx
P. Brito-Zerón, N. Acar-Denizli, V.C. Romão, B. Armagan, R. Seror, F. Carubbi, S. Melchor, R. Priori, V. Valim, S. Retamozo, S.G. Pasoto, V.F.M. Trevisani, B. Hofauer, A. Szántó, N. Inanc, G. Hernández-Molina, A. Sebastian, E. Bartoloni, V. Devauchelle-Pensec, M. Akasbi, F. Giardina, M. Bandeira, A. Sisó-Almirall, M. Ramos-Casals
on behalf of the Sjögren Big Data Consortium
DOI: https://doi.org/10.55563/clinexprheumatol/0anatx
CER14907
2021,39,6,Suppl.133
Pg. 0066-0072
Free to view
Effects of primary Sjögren’s syndrome on female genitalia and sexual functions
M. Gözüküçük, E. Türkyilmaz, O. Küçükşahin, Ş. Erten, Y. Üstün, A.F. Yavuz
DOI: https://doi.org/10.55563/clinexprheumatol/spnjy5
M. Gözüküçük, E. Türkyilmaz, O. Küçükşahin, Ş. Erten, Y. Üstün, A.F. Yavuz
DOI: https://doi.org/10.55563/clinexprheumatol/spnjy5
CER14891
2021,39,6,Suppl.133
Pg. 0073-0079
Free to view
Clinical determinants of vaginal dryness in patients with primary Sjögren’s syndrome
C.A. Farenhorst, L. De Wolff, S. Arends, J.F. Van Nimwegen, F.G.M. Kroese, G.M. Verstappen, H. Bootsma
DOI: https://doi.org/10.55563/clinexprheumatol/hzveng
C.A. Farenhorst, L. De Wolff, S. Arends, J.F. Van Nimwegen, F.G.M. Kroese, G.M. Verstappen, H. Bootsma
DOI: https://doi.org/10.55563/clinexprheumatol/hzveng
CER14929
2021,39,6,Suppl.133
Pg. 0080-0084
Free to view
Combined seronegativity in Sjögren’s syndrome
L.G. Chatzis, V. Pezoulas, P.V. Voulgari, C. Baldini, T.P. Exarchos, D.I. Fotiadis, C.P. Mavragani, F.N. Skopouli, H.M. Moutsopoulos, A.G. Tzioufas, A.V. Goules
DOI: https://doi.org/10.55563/clinexprheumatol/47a4kr
L.G. Chatzis, V. Pezoulas, P.V. Voulgari, C. Baldini, T.P. Exarchos, D.I. Fotiadis, C.P. Mavragani, F.N. Skopouli, H.M. Moutsopoulos, A.G. Tzioufas, A.V. Goules
DOI: https://doi.org/10.55563/clinexprheumatol/47a4kr
CER15011
2021,39,6,Suppl.133
Pg. 0085-0092
Free to view
Differences in presentation between paediatric- and adult-onset primary Sjögren’s syndrome patients
G.E. Legger, M.B. Erdtsieck, L. De Wolff, A.J. Stel, L.I. Los, G.M. Verstappen, F.K. Spijkervet, A. Vissink, B. Van Der Vegt, F.G. Kroese, W. Armbrust, S. Arends, H. Bootsma
DOI: https://doi.org/10.55563/clinexprheumatol/vxe6h0
G.E. Legger, M.B. Erdtsieck, L. De Wolff, A.J. Stel, L.I. Los, G.M. Verstappen, F.K. Spijkervet, A. Vissink, B. Van Der Vegt, F.G. Kroese, W. Armbrust, S. Arends, H. Bootsma
DOI: https://doi.org/10.55563/clinexprheumatol/vxe6h0
CER14894
2021,39,6,Suppl.133
Pg. 0093-0099
Free to view
Work productivity and activity impairment in patients with primary Sjögren's syndrome
M.V. Bejarano, F. Romanini, A. Catalán Pellet, M.N. Mamani, S. Papasidero, J. Demarchi, C.A. Asnal, C.E. Crow, A. Nitsche, L. Encinas, F. Caeiro, C.A. Gobbi, E. Albiero, A. Gómez, R. Águila Maldonado, M. García, M.A. Gallardo, E.R. Soriano, L. Raiti, G. Salvatierra, A. Eimon, A. Secco
DOI: https://doi.org/10.55563/clinexprheumatol/6rd9mr
M.V. Bejarano, F. Romanini, A. Catalán Pellet, M.N. Mamani, S. Papasidero, J. Demarchi, C.A. Asnal, C.E. Crow, A. Nitsche, L. Encinas, F. Caeiro, C.A. Gobbi, E. Albiero, A. Gómez, R. Águila Maldonado, M. García, M.A. Gallardo, E.R. Soriano, L. Raiti, G. Salvatierra, A. Eimon, A. Secco
DOI: https://doi.org/10.55563/clinexprheumatol/6rd9mr
CER14992
2021,39,6,Suppl.133
Pg. 0100-0106
Free to view
Development and performance of the Clinical Trials ESSDAI (ClinTrialsESSDAI), consisting of frequently active clinical domains, in two randomised controlled trials in primary Sjögren’s syndrome
L. De Wolff, S. Arends, E. Pontarini, M. Bombardieri, S.J. Bowman, H. Bootsma
DOI: https://doi.org/10.55563/clinexprheumatol/i8g5nd
L. De Wolff, S. Arends, E. Pontarini, M. Bombardieri, S.J. Bowman, H. Bootsma
DOI: https://doi.org/10.55563/clinexprheumatol/i8g5nd
CER15145
2021,39,6,Suppl.133
Pg. 0107-0113
Free to view
Traditional and disease-related non-computed variables affect algorithms for cardiovascular risk estimation in Sjögren's syndrome and rheumatoid arthritis
G. Cafaro, C. Perricone, I. Riccucci, R. Bursi, S. Calvacchi, A. Alunno, F. Carubbi, R. Gerli, E. Bartoloni
DOI: https://doi.org/10.55563/clinexprheumatol/xef8uz
G. Cafaro, C. Perricone, I. Riccucci, R. Bursi, S. Calvacchi, A. Alunno, F. Carubbi, R. Gerli, E. Bartoloni
DOI: https://doi.org/10.55563/clinexprheumatol/xef8uz
CER15103
2021,39,6,Suppl.133
Pg. 0114-0122
Free to view
Hypergammaglobulinaemia predicts glandular and extra-glandular damage in primary Sjögren’s syndrome: results from the KISS cohort study
J.H. Koh, Y. Park, J. Lee, S.-H. Park, S.-K. Kwok
DOI: https://doi.org/10.55563/clinexprheumatol/volsh1
J.H. Koh, Y. Park, J. Lee, S.-H. Park, S.-K. Kwok
DOI: https://doi.org/10.55563/clinexprheumatol/volsh1
CER15234
2021,39,6,Suppl.133
Pg. 0123-0130
Free to view
Patient-reported experience and health-related quality of life in patients with primary Sjögren's syndrome in Europe
C. Seghieri, E. Lupi, A.G. Tzioufas, S. De Vita, C. Baldini
DOI: https://doi.org/10.55563/clinexprheumatol/vsv60z
C. Seghieri, E. Lupi, A.G. Tzioufas, S. De Vita, C. Baldini
DOI: https://doi.org/10.55563/clinexprheumatol/vsv60z
CER15206
2021,39,6,Suppl.133
Pg. 0131-0139
Free to view
Serum CXCL13, BAFF, IL-21 and IL-22 levels are related to disease activity and lymphocyte profile in primary Sjögren’s syndrome
J. Loureiro-Amigo, C. Franco-Jarava, J. Perurena-Prieto, C. Palacio, F. Martínez-Valle, R. Soláns-Laqué
DOI: https://doi.org/10.55563/clinexprheumatol/fp741f
J. Loureiro-Amigo, C. Franco-Jarava, J. Perurena-Prieto, C. Palacio, F. Martínez-Valle, R. Soláns-Laqué
DOI: https://doi.org/10.55563/clinexprheumatol/fp741f
CER14889
2021,39,6,Suppl.133
Pg. 0140-0145
Free to view
Concomitant fibromyalgia in primary Sjögren's syndrome in the French ASSESS cohort: comparison of the ACR 1990 and ACR 2016 criteria, FiRST questionnaire and physician's opinion
J.-J. Dubost, M. Couderc, B. Pereira, X. Mariette, R. Seror, J.-E. Gottenberg, E. Hachulla, V. Le Guern, A. Saraux, J. Morel, C. Salliot, A. Tournadre, M. Soubrier
DOI: https://doi.org/10.55563/clinexprheumatol/uxlsh3
J.-J. Dubost, M. Couderc, B. Pereira, X. Mariette, R. Seror, J.-E. Gottenberg, E. Hachulla, V. Le Guern, A. Saraux, J. Morel, C. Salliot, A. Tournadre, M. Soubrier
DOI: https://doi.org/10.55563/clinexprheumatol/uxlsh3
Diagnosis
CER14443
2021,39,6,Suppl.133
Pg. 0146-0152
Free to view
Factors associated with delayed diagnosis of Sjögren’s syndrome among members of the Japanese Sjögren’s Association for Patients
K. Komori, M. Komori, T. Horino, S. Nishiyama, M. Takei, N. Suganuma
DOI: https://doi.org/10.55563/clinexprheumatol/s8l2n0
K. Komori, M. Komori, T. Horino, S. Nishiyama, M. Takei, N. Suganuma
DOI: https://doi.org/10.55563/clinexprheumatol/s8l2n0
CER14627
2021,39,6,Suppl.133
Pg. 0153-0158
Free to view
Factors influencing the EULAR Sjögren’s Syndrome Patient-Reported Index in primary Sjögren’s syndrome
M.G. Sandoval-Flores, I. Chan-Campos, G. Hernández-Molina
DOI: https://doi.org/10.55563/clinexprheumatol/mvcai5
M.G. Sandoval-Flores, I. Chan-Campos, G. Hernández-Molina
DOI: https://doi.org/10.55563/clinexprheumatol/mvcai5
CER14744
2021,39,6,Suppl.133
Pg. 0159-0165
Free to view
A cohort study of T helper 17 cell-related cytokine levels in tear samples of systemic lupus erythematosus and Sjögren’s syndrome patients with dry eye disease
X. Peng, Y. Lu, J. Wei, T. Lin, Q. Lu, Q. Liu, W.-J. Ting
DOI: https://doi.org/10.55563/clinexprheumatol/tlnr4z
X. Peng, Y. Lu, J. Wei, T. Lin, Q. Lu, Q. Liu, W.-J. Ting
DOI: https://doi.org/10.55563/clinexprheumatol/tlnr4z
CER14934
2021,39,6,Suppl.133
Pg. 0166-0174
Free to view
Influence of the age at diagnosis in the disease expression of primary Sjögren syndrome. Analysis of 12,753 patients from the Sjögren Big Data Consortium
S. Retamozo, N. Acar-Denizli, I.F. Horváth, W.-F. Ng, A. Rasmussen, X. Dong, X. Li, C. Baldini, P. Olsson, R. Priori, R. Seror, J.-E. Gottenberg, A.A. Kruize, G. Hernandez-Molina, A. Vissink, P. Sandhya, B. Armagan, L. Quartuccio, A. Sebastian, S. Praprotnik, E. Bartoloni, S.-K. Kwok, M. Kvarnstrom, M. Rischmueller, R. Soláns-Laqué, D. Sene, S.G. Pasoto, Y. Suzuki, D.A. Isenberg, V. Valim, G. Nordmark, H. Nakamura, V. Fernandes Moça Trevisani, B. Hofauer, A. Sisó-Almirall, R. Giacomelli, V. Devauchelle-Pensec, M. Bombardieri, F. Atzeni, D. Hammenfors, B. Maure, S.E. Carsons, T. Gheita, I. Sánchez-Berná, M. López-Dupla, J. Morel, N. Inanç, E. Fonseca-Aizpuru, C. Morcillo, C. Vollenweider, S. Melchor, M. Vázquez, E. Díaz-Cuiza, S. Consani-Fernández, B. De-Miguel-Campo, A. Szántó, S. Bombardieri, A. Gattamelata, A. Hinrichs, J. Sánchez-Guerrero, D. Danda, L. Kilic, S. De Vita, P. Wiland, R. Gerli, S.-H. Park, M. Wahren-Herlenius, H. Bootsma, X. Mariette, M. Ramos-Casals, P. Brito-Zerón
Sjögren Big Data Consortium
DOI: https://doi.org/10.55563/clinexprheumatol/egnd1i
S. Retamozo, N. Acar-Denizli, I.F. Horváth, W.-F. Ng, A. Rasmussen, X. Dong, X. Li, C. Baldini, P. Olsson, R. Priori, R. Seror, J.-E. Gottenberg, A.A. Kruize, G. Hernandez-Molina, A. Vissink, P. Sandhya, B. Armagan, L. Quartuccio, A. Sebastian, S. Praprotnik, E. Bartoloni, S.-K. Kwok, M. Kvarnstrom, M. Rischmueller, R. Soláns-Laqué, D. Sene, S.G. Pasoto, Y. Suzuki, D.A. Isenberg, V. Valim, G. Nordmark, H. Nakamura, V. Fernandes Moça Trevisani, B. Hofauer, A. Sisó-Almirall, R. Giacomelli, V. Devauchelle-Pensec, M. Bombardieri, F. Atzeni, D. Hammenfors, B. Maure, S.E. Carsons, T. Gheita, I. Sánchez-Berná, M. López-Dupla, J. Morel, N. Inanç, E. Fonseca-Aizpuru, C. Morcillo, C. Vollenweider, S. Melchor, M. Vázquez, E. Díaz-Cuiza, S. Consani-Fernández, B. De-Miguel-Campo, A. Szántó, S. Bombardieri, A. Gattamelata, A. Hinrichs, J. Sánchez-Guerrero, D. Danda, L. Kilic, S. De Vita, P. Wiland, R. Gerli, S.-H. Park, M. Wahren-Herlenius, H. Bootsma, X. Mariette, M. Ramos-Casals, P. Brito-Zerón
Sjögren Big Data Consortium
DOI: https://doi.org/10.55563/clinexprheumatol/egnd1i
CER15081
2021,39,6,Suppl.133
Pg. 0175-0183
Free to view
Sonographic features of lymphoma of the major salivary glands diagnosed with ultrasound-guided core needle biopsy in Sjögren’s syndrome
M. Lorenzon, F. Tulipano Di Franco, A. Zabotti, E. Pegolo, I. Giovannini, V. Manfrè, E. Mansutti, S. De Vita, C. Zuiani, R. Girometti
DOI: https://doi.org/10.55563/clinexprheumatol/4c36nr
M. Lorenzon, F. Tulipano Di Franco, A. Zabotti, E. Pegolo, I. Giovannini, V. Manfrè, E. Mansutti, S. De Vita, C. Zuiani, R. Girometti
DOI: https://doi.org/10.55563/clinexprheumatol/4c36nr
CER14941
2021,39,6,Suppl.133
Pg. 0184-0189
Free to view
Sonoelastography of salivary glands for diagnosis and clinical evaluation in primary Sjögren’s syndrome
X. Zhang, S. Zhang, R. Feng, H. Yao, S. Tang, J. He
DOI: https://doi.org/10.55563/clinexprheumatol/6nu95q
X. Zhang, S. Zhang, R. Feng, H. Yao, S. Tang, J. He
DOI: https://doi.org/10.55563/clinexprheumatol/6nu95q
Treatment
CER15172
2021,39,6,Suppl.133
Pg. 0190-0196
Free to view
Adherence to the Mediterranean diet and the impact on clinical features in primary Sjögren’s syndrome
F. Carubbi, A. Alunno, F. Mai, A. Mercuri, D. Centorame, J. Cipollone, F.M. Mariani, M. Rossi, E. Bartoloni, D. Grassi, C. Ferri
DOI: https://doi.org/10.55563/clinexprheumatol/5p5x5p
F. Carubbi, A. Alunno, F. Mai, A. Mercuri, D. Centorame, J. Cipollone, F.M. Mariani, M. Rossi, E. Bartoloni, D. Grassi, C. Ferri
DOI: https://doi.org/10.55563/clinexprheumatol/5p5x5p
Reviews
CER14903
2021,39,6,Suppl.133
Pg. 0197-0205
Free to view
Practical guidelines for the early diagnosis of Sjögren’s syndrome in primary healthcare
A. Sisó-Almirall, J.M. Meijer, P. Brito-Zerón, L. Conangla, A. Flores-Chavez, L. González De Paz, H. Bootsma, M. Ramos-Casals
DOI: https://doi.org/10.55563/clinexprheumatol/pal3z7
A. Sisó-Almirall, J.M. Meijer, P. Brito-Zerón, L. Conangla, A. Flores-Chavez, L. González De Paz, H. Bootsma, M. Ramos-Casals
DOI: https://doi.org/10.55563/clinexprheumatol/pal3z7
CER14945
2021,39,6,Suppl.133
Pg. 0206-0214
Free to view
Searching for the “X factor” in Sjögren’s syndrome female predilection
L.G. Chatzis, A.V. Goules, A.G. Tzioufas
DOI: https://doi.org/10.55563/clinexprheumatol/88dyrn
L.G. Chatzis, A.V. Goules, A.G. Tzioufas
DOI: https://doi.org/10.55563/clinexprheumatol/88dyrn
CER15166
2021,39,6,Suppl.133
Pg. 0215-0222
Free to view
Severity of COVID-19 infection in primary Sjögren’s syndrome and the emerging evidence of COVID-19-induced xerostomia
F. Chowdhury, S. Grigoriadou, M. Bombardieri
DOI: https://doi.org/10.55563/clinexprheumatol/k7x3ta
F. Chowdhury, S. Grigoriadou, M. Bombardieri
DOI: https://doi.org/10.55563/clinexprheumatol/k7x3ta
Letters to the Editor
CER14485
2021,39,6,Suppl.133
Pg. 0223-0224
Free to view
Type II cryoglobulinaemic vasculitis with primary Sjögren's syndrome successfully treated with belimumab and hydroxychloroquine
S. Izuka, H. Yamashita, Y. Takahashi, H. Kaneko
DOI: https://doi.org/10.55563/clinexprheumatol/7r8crm
S. Izuka, H. Yamashita, Y. Takahashi, H. Kaneko
DOI: https://doi.org/10.55563/clinexprheumatol/7r8crm
CER14505
2021,39,6,Suppl.133
Pg. 0225
Free to view
Plasma cell gingivitis, an underestimated condition in patients with Sjögren’s syndrome?
L. Genet, M. Jalladaud, R. Seror, M. Gosset
DOI: https://doi.org/10.55563/clinexprheumatol/g1ll8c
L. Genet, M. Jalladaud, R. Seror, M. Gosset
DOI: https://doi.org/10.55563/clinexprheumatol/g1ll8c
CER13837
2021,39,6,Suppl.133
Pg. 0226-0227
Free to view
Primary Sjögren’s syndrome with minimal change disease: case series and literature review
J. Lang, X. Shi, Y. Ma, L. Zou, Y. Fei, L. Chen
DOI: https://doi.org/10.55563/clinexprheumatol/5harco
J. Lang, X. Shi, Y. Ma, L. Zou, Y. Fei, L. Chen
DOI: https://doi.org/10.55563/clinexprheumatol/5harco
CER14916
2021,39,6,Suppl.133
Pg. 0228-0229
Free to view
COVID-19 vaccination unveiling subclinical Sjögren's syndrome
M. Ramos-Casals, M. Sainz-De-La-Maza, A. Muxí
DOI: https://doi.org/10.55563/clinexprheumatol/u1v6z1
M. Ramos-Casals, M. Sainz-De-La-Maza, A. Muxí
DOI: https://doi.org/10.55563/clinexprheumatol/u1v6z1
CER15185
2021,39,6,Suppl.133
Pg. 0230
Free to view
Sjögren’s syndrome and pulmonary alveolar proteinosis co-existence
B. Gundogus, T. Yildiz, M. Agca, A. Erdagi, H. Yilmaz
DOI: https://doi.org/10.55563/clinexprheumatol/857d4n
B. Gundogus, T. Yildiz, M. Agca, A. Erdagi, H. Yilmaz
DOI: https://doi.org/10.55563/clinexprheumatol/857d4n